Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2024-01-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
美好医疗对外担保管理制度（2024年1月修订）
Governance Information Classification · 95% confidence The document is titled '深圳市美好创亿医疗科技股份有限公司 对外担保管理制度' which translates to 'Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. External Guarantee Management System'. It is a detailed internal policy document outlining the rules, responsibilities, approval processes, risk management, and penalties related to the company's external guarantees. It references relevant laws and regulations, company governance, and internal procedures. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. It is not a report publication announcement or certification. The document is a governance-related internal policy document, detailing the company's internal rules and governance practices regarding external guarantees. Therefore, the most appropriate classification is Governance Information (CGR). The document length (4908 characters) and content support this classification with high confidence.
2024-01-30 Chinese
关于部分募集资金投资项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the delay of certain investment projects funded by proceeds from their initial public offering (IPO). It details the postponement of the expected usable date of a key project, provides background on the fundraising, investment progress, reasons for the delay, and the impact on the company. It also includes approvals from the board of directors, supervisory board, and the sponsor institution's opinions. The document is relatively short (3129 characters) and serves as a formal disclosure about the delay of the use of raised funds rather than a full financial report or detailed financial data. It does not contain financial statements or comprehensive financial analysis. This type of announcement fits best under the category of Capital/Financing Update (CAP), as it relates to updates on the use and progress of capital raised through financing activities (IPO proceeds).
2024-01-30 Chinese
美好医疗防范大股东及其关联方资金占用制度（2024年1月修订）
Governance Information Classification · 95% confidence The document is titled '防范大股东及其关联方资金占用制度' which translates to 'Prevention of Major Shareholders and Their Related Parties' Fund Occupation System'. It is a detailed internal policy document issued by Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. dated January 2024. The content outlines principles, responsibilities, and measures to prevent the misuse or occupation of company funds by major shareholders and their related parties. It includes governance and compliance rules, responsibilities of directors and management, and penalties for violations. There is no indication that this is a financial report, audit report, earnings release, or any form of regulatory filing or announcement. Instead, it is a governance-related internal policy document focused on corporate governance and internal control mechanisms regarding fund occupation by major shareholders. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4585 characters, which is substantive and not a mere announcement or certification, supporting this classification.
2024-01-30 Chinese
美好医疗独立董事工作制度（2024年1月修订）
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It is a detailed internal governance document outlining the qualifications, duties, nomination, election, and operational procedures for independent directors of the company. It references relevant laws, regulations, and stock exchange rules, and includes chapters on the responsibilities and protections of independent directors. The document is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and practices concerning the board of directors. Therefore, it fits best under the category of Governance Information (CGR). The document length (over 10,000 characters) and content confirm it is the actual governance policy, not just an announcement or summary.
2024-01-30 Chinese
第二届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the seventh meeting of the second supervisory board of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details the meeting's convening, attendance, and the approval of a proposal regarding the postponement of some fundraising investment projects. The document includes voting results and references compliance with relevant laws and stock exchange rules. It does not contain financial statements, detailed financial analysis, or full report content. The document is relatively short (824 characters) and serves as an official announcement of a board meeting decision rather than a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2024-01-30 Chinese
美好医疗董事会专门委员会工作制度（2024年1月修订）
Governance Information Classification · 95% confidence The document is titled '董事会专门委员会工作制度' which translates to 'Board Special Committee Working System'. It details the structure, responsibilities, composition, and procedural rules of the company's board committees such as the audit committee, remuneration committee, strategy committee, and nomination committee. The content focuses on governance practices, committee duties, meeting rules, and internal control oversight. There is no financial data, earnings information, voting results, or announcements of reports. The document is a governance-related internal rules document describing board committee operations and governance structure. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and it is not a brief announcement or certification, so it is not RPA or RNS. Hence, the classification is CGR with high confidence.
2024-01-30 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.